Integra Lifesciences Holdings Corporation target price cut to $13 from $15
IART•Truist Securities cut its target price for Integra Lifesciences Holdings Corporation to $13 from $15.
Related News
European Commission looks into starting plastics safeguard investigation
XLB•
Rentokil Initial Chair Thérèse Esperdy’s trust buys 10,881 ADSs
RTO•
UBS Group holds 3.48% of Dürr voting rights
UBS•
Canadian jet maker Bombardier plans new $270 million US investment
BDRBF•
Novartis’ remibrutinib reduces MS relapses versus teriflunomide in Phase III trials
NVS•